These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CgA AND Staging
10 results:

  • 1. Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring lung Well-Differentiated Neuroendocrine Tumors: A Brief Report.
    Nisman B; Oleinikov K; Nechushtan H; Maimon O; Atlan K; Peled N; Gross D; Peretz T; Meirovitz A; Grozinsky-Glasberg S
    J Thorac Oncol; 2023 Mar; 18(3):369-376. PubMed ID: 36503175
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [On detection of chromogranin A, synaptophysin, neuronspecific enolase and progastrin-releasing peptide in small cell lung cancer].
    Lu QQ; Li J; Li YH; Liu H; Xie XB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jul; 56(7):1017-1022. PubMed ID: 35899358
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.
    Ni J; Zhang X; Wang H; Si X; Xu Y; Zhao J; Chen M; Zhang L; Wang M
    Thorac Cancer; 2022 Feb; 13(4):539-548. PubMed ID: 34970848
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.
    Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
    Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.
    Hörsch D; Schmid KW; Anlauf M; Darwiche K; Denecke T; Baum RP; Spitzweg C; Grohé C; Presselt N; Stremmel C; Heigener DF; Serke M; Kegel T; Pavel M; Waller CF; Deppermann KM; Arnold R; Huber RM; Weber MM; Hoffmann H
    Oncol Res Treat; 2014; 37(5):266-76. PubMed ID: 24853787
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer.
    Petrović M; Bukumirić Z; Zdravković V; Mitrović S; Atkinson HD; Jurišić V
    Med Oncol; 2014 Feb; 31(2):823. PubMed ID: 24375395
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Selected neuroendocrine tumour markers, growth factors and their receptors in typical and atypical bronchopulmonary carcinoids.
    Telega A; Kos-Kudła B; Foltyn W; Blicharz-Dorniak J; Rosiek V
    Endokrynol Pol; 2012; 63(6):477-82. PubMed ID: 23339006
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chromogranin A--serum marker for prostate cancer.
    Khan MO; Ather MH
    J Pak Med Assoc; 2011 Jan; 61(1):108-11. PubMed ID: 22368921
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role.
    Cimitan M; Buonadonna A; Cannizzaro R; Canzonieri V; Borsatti E; Ruffo R; De Apollonia L
    Ann Oncol; 2003 Jul; 14(7):1135-41. PubMed ID: 12853358
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
    Giovanella L; Ceriani L; Bandera M; Garancini S
    Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.